TCR2 THERAPEUTICS INC.

TCRR NASDAQ
12.63
-0.24
-1.86%
盘后: 12.76 +0.13 +1.03% 17:04 07/16 EDT
开盘
12.95
昨收
12.87
最高
13.08
最低
12.59
成交量
1.09万
成交均量(3M)
2.64万
52周最高
25.47
52周最低
12.59
换手率
0.05%
市值
2.93亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供TCR2 THERAPEUTICS INC. TCRR股票价格,TCR2 THERAPEUTICS INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

TCR2 Therapeutics, Inc. is an immunotherapy company, which is developing novel T cell therapies for patients suffering from cancer. The Company’s T cell receptor (TCR) Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing the entire T cell receptor (TCR) signaling complex. The Company has demonstrated anti-tumor activity of TRuC-T cells in preclinical models across various tumor targets. The Company has also developed combinations of TRuC variants with elements designed to sustain the immunotherapeutic response and counteract the immunosuppressive tumor microenvironment. Its platform is highlighted with multiple programs of product candidate, which include TC-210, TC-220, TC-410, TC-110 and TC-310.
展开 >

最近浏览

名称
价格
涨跌幅